BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30246494)

  • 41. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
    Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
    Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.
    de Jong A; Dirven RJ; Oud JA; Tio D; van Vlijmen BJM; Eikenboom J
    J Thromb Haemost; 2018 Jul; 16(7):1357-1368. PubMed ID: 29734512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Acta Haematol; 2009; 121(2-3):98-101. PubMed ID: 19506354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model.
    Lemmerhirt HL; Broman KW; Shavit JA; Ginsburg D
    J Thromb Haemost; 2007 Feb; 5(2):329-35. PubMed ID: 17155961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.
    Hickson N; Hampshire D; Winship P; Goudemand J; Schneppenheim R; Budde U; Castaman G; Rodeghiero F; Federici AB; James P; Peake I; Eikenboom J; Goodeve A;
    J Thromb Haemost; 2010 Sep; 8(9):1986-93. PubMed ID: 20492463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.
    Lapić I; Radić Antolic M; Boban A; Coen Herak D; Rogić D; Zadro R
    Croat Med J; 2022 Apr; 63(2):166-175. PubMed ID: 35505650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. von Willebrand factor sialylation-A critical regulator of biological function.
    Ward S; O'Sullivan JM; O'Donnell JS
    J Thromb Haemost; 2019 Jul; 17(7):1018-1029. PubMed ID: 31055873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
    Bowen DJ; Collins PW
    Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
    Goodeve A; Eikenboom J; Castaman G; Rodeghiero F; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Habart D; Vorlova Z; Holmberg L; Lethagen S; Pasi J; Hill F; Hashemi Soteh M; Baronciani L; Hallden C; Guilliatt A; Lester W; Peake I
    Blood; 2007 Jan; 109(1):112-21. PubMed ID: 16985174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New advances in the diagnosis of von Willebrand disease.
    Sharma R; Haberichter SL
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):596-600. PubMed ID: 31808831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.
    Nichols WC; Cooney KA; Mohlke KL; Ballew JD; Yang A; Bruck ME; Reddington M; Novak EK; Swank RT; Ginsburg D
    Blood; 1994 Jun; 83(11):3225-31. PubMed ID: 8193357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
    Souto JC; Almasy L; Soria JM; Buil A; Stone W; Lathrop M; Blangero J; Fontcuberta J
    Thromb Haemost; 2003 Mar; 89(3):468-74. PubMed ID: 12624629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A.
    Nichols TC; Bellinger DA; Reddick RL; Smith SV; Koch GG; Davis K; Sigman J; Brinkhous KM; Griggs TR; Read MS
    Blood; 1993 May; 81(10):2644-51. PubMed ID: 8490173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New variant of von Willebrand disease with defective binding to factor VIII.
    Nishino M; Girma JP; Rothschild C; Fressinaud E; Meyer D
    Blood; 1989 Oct; 74(5):1591-9. PubMed ID: 2506947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes.
    Wang QY; Song J; Gibbs RA; Boerwinkle E; Dong JF; Yu FL
    J Thromb Haemost; 2013 Feb; 11(2):261-9. PubMed ID: 23216583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease.
    Millar CM; Brown SA
    Blood Rev; 2006 Mar; 20(2):83-92. PubMed ID: 16507387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.